Evidence map›Paper›PMID 38557827›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Zacopride stimulates 5-HT

Joachim Neumann, Christin Hesse, Britt Hofmann, Ulrich Gergs

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Felcisetrag stimulates 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  3. Article
  4. A Drug Screening Platform for Podocytopathies in Drosophila Nephrocytes.Journal of the American Society of Nephrology : JASN · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Joachim NeumannInstitute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06097, Halle (Saale), Germany. joachim.neumann@medizin.uni-halle.de.
Christin HesseInstitute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06097, Halle (Saale), Germany.
Britt HofmannDepartment of Cardiac Surgery, Mid-German Heart Center, University Hospital Halle, Ernst-Grube-Straße 40, D-06097, Halle (Saale), Germany.
Ulrich GergsInstitute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06097, Halle (Saale), Germany.
Martin Luther University Halle-Wittenberg · DEUniversity Hospital in Halle · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zacopride (4-amino-5-chloro-2-methoxy-N-(quinuclidin-3-yl)-benzamide) is a potent agonist in human 5-HT

Indexed as

BenzamidesHeart AtriaReceptors, Serotonin, 5-HT4Serotonin 5-HT4 Receptor AgonistsAnimalsBridged Bicyclo Compounds, HeterocyclicHumansIn Vitro TechniquesMaleMiceMice, Inbred C57BLMyocardial ContractionSerotonin 5-HT4 Receptor AntagonistsBenzamidesBridged Bicyclo Compounds, HeterocyclicReceptors, Serotonin, 5-HT4Serotonin 5-HT4 Receptor AgonistsSerotonin 5-HT4 Receptor Antagonistszacopride5-HT4Human atriumMouse atriumSerotonin receptorsTransgenic miceZacopride

Identifiers

PMID38557827
PMCPMC11422277
OpenAlexW4393392586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.